TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive Carcinogenicity Test For Cis-Platinum Needed, DCT Says, But Declines To Pay For It June 16, 1978
TCL Archive VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds July 25, 2008